Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
JCI Insight|June 24, 2025
MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapyKeisuke Shigeta, Tatsuaki Daimon, Hiroshi Hongo, et al.
NPJ Breast Cancer|April 26, 2025
MUC1-C dependency in drug resistant HR+/HER2- breast cancer identifies a new target for antibody-drug conjugate treatmentAyako Nakashoji, Atrayee Bhattacharya, Hiroki Ozawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2025
Targeting KRAS Inhibitor-Resistant Pancreatic Cancer with an MUC1-C Antibody-Drug ConjugateHiroki Ozawa, Kazuki Takahashi, Tomoki Motegi, et al.
International Journal of Clinical Oncology|March 28, 2024
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022Shoji Kimura, Keisuke Shigeta, Shingo Tamura, et al.
International Journal of Clinical Oncology|March 22, 2024
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022Keita Uchino, Shingo Tamura, Shoji Kimura, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
Pageof 6